RÉSUMÉ
BACKGROUND: This study aimed to assess the learning curve (LC) of cytoredutive surgery (CRS) of peritoneal metastasis (PM) from colorectal cancer (CRC). Information about learning curves is important for developing teaching tools and well-structured training programs for the implementation of this complex procedure in new healthcare centers. The aim of this study was to estimate how many procedures an inexperienced surgeon must perform (the length of the learning period) in order to demonstrate an acceptably low rate of locoregional recurrence. METHODS: All consecutive 74 patients with CRS for CRC performed by a novice surgeon between 2012 and 2017 in a tertiary cancer center were included. The learning curve was calculated by a cumulative sum control chart (CUSUM) graph. Two groups were formed based on the length of the learning period and were compared on overall and disease free survival. RESULTS: The risk of locoregional recurrence decreased after surgeons had performed 19 cases, suggesting a learning period of this length. Overall survival and postoperative morbidity were not significantly different between learning and proficiency periods. Multiple linear regression analysis showed that the learning period and peritoneal cancer index are the only factors affecting disease free survival. A second learning period was observed in cases where patient care became more complex. CONCLUSIONS: This study confirms that learning period has negative impacts on disease-free survival. An initial experience supervised in specialized centers allow to have a short learning curve for CRS for peritoneal metastases for CRC.
Sujet(s)
Protocoles de polychimiothérapie antinéoplasique/administration et posologie , Carcinomes/chirurgie , Tumeurs colorectales/chirurgie , Interventions chirurgicales de cytoréduction/enseignement et éducation , Chimiothérapie hyperthermique intrapéritonéale , Courbe d'apprentissage , Tumeurs du péritoine/chirurgie , Complications postopératoires/épidémiologie , Adulte , Sujet âgé , Carcinomes/secondaire , Cholécystectomie , Colectomie , Tumeurs colorectales/anatomopathologie , Interventions chirurgicales de cytoréduction/méthodes , Survie sans rechute , Femelle , Humains , Irinotécan/administration et posologie , Modèles linéaires , Mâle , Métastasectomie/enseignement et éducation , Métastasectomie/méthodes , Adulte d'âge moyen , Mitomycine/usage thérapeutique , Traitement néoadjuvant , Omentum/chirurgie , Oxaliplatine/administration et posologie , Tumeurs du péritoine/secondaire , Proctectomie , Salpingo-ovariectomieRÉSUMÉ
OBJECTIVE: This study was performed to examine the safety of bowel resection and upper abdominal surgery in patients with advanced ovarian cancer performed by gynecologic oncologists after training in a monodisciplinary surgical team. METHODS: We implemented a monodisciplinary surgical team consisting of specialized gynecologic oncologist for advanced ovarian cancer. In the initial learning period in 65 patients with International Federation of Gynecology and Obstetrics (FIGO) III/IV, a gynecologic oncologist who had a certification as a general surgeon trained 2 other gynecologic oncologists in bowel resection and upper abdominal surgery for 4 years. After the initial learning period, the trained gynecologic oncologists performed surgeries without the certificated general surgeon in 195 patients with FIGO III/IV. The surgical outcomes and perioperative complications during the 2 periods were evaluated. RESULTS: The rates of achieving no gross disease after cytoreductive surgery were 80.0% in the initial learning period and 83.6% in the post-learning period (p=0.560). The incidence of anastomotic leakage after rectosigmoid resection, symptomatic pleural effusion or pneumothorax after right diaphragm resection, and pancreatic fistula after splenectomy with distal pancreatectomy in the 2 periods were 2 of 34 (6.0%), 1 of 33 (3.0%), and 3 of 15 (20.0%) patients in the initial learning period, and 12 of 147 (8.2%), 1 of 118 (0.8%), and 11 of 84 (13.1%) patients in the post-learning period, respectively. There were no significant differences between the 2 groups (p=0.270, p=0.440, p=0.520, respectively). CONCLUSION: Bowel resection and upper abdominal surgery can be performed safely by gynecologic oncologists.
Sujet(s)
Interventions chirurgicales de cytoréduction/enseignement et éducation , Procédures de chirurgie digestive/enseignement et éducation , Procédures de chirurgie gynécologique/enseignement et éducation , Sujet âgé , Femelle , Gynécologie/enseignement et éducation , Humains , Oncologie médicale/enseignement et éducation , Adulte d'âge moyen , Tumeurs de l'ovaire/chirurgie , Mise au point de programmes , Études prospectives , Spécialisation/normesRÉSUMÉ
OBJECTIVE: We investigated the learning curve for a monodisciplinary surgical team consisting of gynecologic oncologists performing cytoreductive surgery for advanced ovarian cancer, involving high-complexity procedures with bowel resection and upper abdominal surgery. METHODS: We investigated 271 consecutive patients with ovarian, fallopian tube, and peritoneal carcinoma undergoing cytoreductive surgery for stage III/IV disease. All operations were performed by a team consisting of only gynecologic oncologists. Patients were classified into 2 groups depending on the surgical complexity score (a cumulative score based on complexity and number of procedures performed). Learning curves for patients with moderate (4-7, 63 patients) and high scores (8-18, 208 patients) were evaluated using cumulative sum (CUSUM) analysis of operative time, total blood loss, and perioperative complications. RESULTS: Operative time and total blood loss showed a learning curve. The CUSUM curve for operative time peaked at the 28th and 51st case in the moderate- and high-score groups, respectively. The CUSUM curve for total blood loss peaked at the 16th and 55th case in the moderate- and high-score groups, respectively. The CUSUM curve for complications (Clavien-Dindo ≥ IIIb) showed a downward slope after the 6th case in the high-score group and remained within the acceptable range throughout the study. CONCLUSION: Proficiency in performing high-complexity surgery was achieved after approximately 50 cases and this number is greater than the number of cases required to perform moderate-complexity surgery. Acceptable rates of severe perioperative complications were observed even during the initial learning period in cases of high-complexity surgery.
Sujet(s)
Interventions chirurgicales de cytoréduction/enseignement et éducation , Procédures de chirurgie gynécologique/enseignement et éducation , Tumeurs de l'ovaire/chirurgie , Sujet âgé , Interventions chirurgicales de cytoréduction/méthodes , Femelle , Procédures de chirurgie gynécologique/méthodes , Humains , Hystérectomie/enseignement et éducation , Hystérectomie/méthodes , Courbe d'apprentissage , Adulte d'âge moyen , Stadification tumorale , Tumeurs de l'ovaire/anatomopathologie , Ovariectomie/enseignement et éducation , Ovariectomie/méthodes , Salpingo-ovariectomie/enseignement et éducation , Salpingo-ovariectomie/méthodesRÉSUMÉ
BACKGROUND: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is an accepted therapeutic approach in selected patients with peritoneal malignancy. The aim of this study was to describe early outcomes in the first 50 patients managed with CRS and HIPEC in a newly established peritoneal malignancy centre in Sydney, Australia, under the guidance of an experienced peritoneal malignancy mentor. METHODS: This is a retrospective review of a prospective maintained database of early outcomes in the first 50 patients who underwent CRS and HIPEC between April 2017 and April 2018 at a newly established peritoneal malignancy centre. Type of primary, surgery time, length of hospital stay, blood loss, peritoneal carcinomatosis index, completeness of surgery, complications, recurrence rate and 30-day mortality were reviewed. RESULTS: A total of 135 patients were referred and reviewed at the multidisciplinary team meeting with 50 (26 male) patients undergoing CRS and HIPEC. Of these 50 patients, 47 (94%) underwent complete cytoreduction while three (6%) had maximal tumour debulking surgery. Tumour pathology was of appendix origin (44%) and colorectal peritoneal metastases (44%). Median surgical time was 7.4 h (interquartile range 5.7-10.0). Median length of hospital stay was 13 days (interquartile range 9.7-19.0). Six (12%) patients experienced a grade III or IV Clavien-Dindo complication. There was no 30-day mortality. CONCLUSION: This study reports the successful establishment of a peritoneal malignancy centre under the guidance of an experienced peritoneal malignancy mentor. The short-term surgical outcomes observed in the first 50 cases are promising and comparable to other more experienced centres.
Sujet(s)
Interventions chirurgicales de cytoréduction/enseignement et éducation , Hyperthermie provoquée , Courbe d'apprentissage , Mentors , Tumeurs du péritoine/thérapie , Femelle , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Facteurs temps , Résultat thérapeutiqueRÉSUMÉ
BACKGROUND: Combined cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC) has been considered as a standard approach for peritoneal surface malignancy. This study aims to assess the learning curve of this combined approach. METHODS: Prospectively collected data of our first 800 consecutive patients treated by CRS and PIC between January 1996 and July 2014 were retrospectively reviewed. Eight hundred patients were divided into two groups and eight groups for comparison. A significant difference was defined as P < 0.05. RESULTS: A significant increase in the rate of the completeness of cytoreduction (CC) score-0 from 74.0% to 83.0% was seen with a reduction in rates of other CC scores. Also, there was a decreasing trend in mean blood transfusion units. The rate of viscus perforation, fistula formation and small bowel obstruction was significantly lower in the recent 400 patients. However, there was a significant increase in the incidence of deep venous thrombosis and pulmonary embolism. There was an improvement in the 5-year survival rate for patients with colorectal cancer, pseudomyxoma peritonei and mesothelioma. CONCLUSION: Our findings demonstrate a learning curve associated with the combined approach of CRS and PIC. With adequate experience, CRS and PIC can be safely performed with acceptable mortality and morbidity.
Sujet(s)
Perfusion régionale de chimiothérapie anticancéreuse/enseignement et éducation , Interventions chirurgicales de cytoréduction/enseignement et éducation , Courbe d'apprentissage , Soins périopératoires/méthodes , Tumeurs du péritoine/thérapie , Femelle , Humains , Mâle , Adulte d'âge moyen , Nouvelle-Galles du Sud/épidémiologie , Tumeurs du péritoine/mortalité , Études rétrospectives , Taux de survie/tendances , Résultat thérapeutiqueRÉSUMÉ
BACKGROUND: CytoReductive Surgery and Hyperthermic IntraPEritoneal Chemotherapy (CRS-HIPEC) is now the preferred treatment of many peritoneal surface malignancies. In this retrospective study we aimed to analyze how several performance indicators changed during the first 100 CRS-HIPEC procedures in hospitals which recently introduced this treatment, and compare those with an experienced institution. METHODS: The first consecutive 100 CRS-HIPEC procedures of three institutions were compared to those of the pioneer hospital. The training provided by the pioneer hospital consisted of hands-on training during the first ten procedures; hereafter guidance was available on consult basis. Operation characteristics, morbidity and completeness of cytoreduction were evaluated by case sequence. Locally-estimated-scatter-plot smoothing was used to evaluate the learning curve. RESULTS: From four institutions 372 cases were included. A macroscopic complete cytoreduction was reached in 66% of the cases in the pioneer hospital and in 86% in the new hospitals (p < 0.001). Complete cytoreduction rates were higher at start off in the new institutions compared with the experienced institution and increased significantly in the first 100 procedures. The new hospitals started with lower morbidity than the experienced hospital, which did not significantly decrease during the study period. CONCLUSION: New institutions that were trained and mentored by an experienced CRS-HIPEC hospital performed better from the beginning with regard to complete cytoreduction and morbidity rate with than the experienced center. An improvement in complete cytoreduction rate during the first 100 procedures was observed in the new institutions.
Sujet(s)
Antinéoplasiques/administration et posologie , Tumeurs colorectales/anatomopathologie , Interventions chirurgicales de cytoréduction/normes , Hyperthermie provoquée/normes , Courbe d'apprentissage , Mitomycine/administration et posologie , Tumeurs du péritoine/thérapie , Pseudomyxome péritonéal/thérapie , Adulte , Sujet âgé , Interventions chirurgicales de cytoréduction/effets indésirables , Interventions chirurgicales de cytoréduction/enseignement et éducation , Femelle , Humains , Hyperthermie provoquée/effets indésirables , Perfusions parentérales , Formation en interne , Durée du séjour , Mâle , Mentors , Adulte d'âge moyen , Durée opératoire , Tumeurs du péritoine/secondaire , Hémorragie postopératoire , Études rétrospectives , Jeune adulteSujet(s)
Antinéoplasiques/administration et posologie , Interventions chirurgicales de cytoréduction , Hypothermie provoquée , Tumeurs du péritoine/thérapie , Antinéoplasiques/effets indésirables , Interventions chirurgicales de cytoréduction/effets indésirables , Interventions chirurgicales de cytoréduction/enseignement et éducation , Enseignement spécialisé en médecine , Humains , Hypothermie provoquée/effets indésirables , Perfusions parentérales , Oncologie médicale/enseignement et éducation , Sélection de patients , Tumeurs du péritoine/anatomopathologie , Facteurs de risque , Résultat thérapeutiqueRÉSUMÉ
BACKGROUND: The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (PMP) were explored between international centres/surgeons to identify institutional or other factors that might affect performance. METHODS: Data from patients with PMP treated with the combined procedure across 33 international centres between 1993 and 2012 were analysed retrospectively. A risk-adjusted sequential probability ratio test was conducted after defining the target outcome as early oncological failure (disease progression within 2 years of treatment), an acceptable risk for the target outcome (odds ratio) of 2, and type I/II error rates of 5 per cent. The risk prediction model was elaborated and patients were evaluated sequentially for each centre/surgeon. The learning curve was considered to be overcome and proficiency achieved when the odds ratio for early oncological failure became smaller than 2. RESULTS: Rates of optimal cytoreduction, severe postoperative morbidity and early oncological failure were 84·4, 25·7 and 29·0 per cent respectively. The median annual centre volume was 17 (range 6-66) peritoneal malignancies. Only eight of the 33 centres and six of 47 surgeons achieved proficiency after a median of 100 (range 78-284) and 96 (86-284) procedures respectively. The most important institutional factor affecting surgical performance was centre volume. CONCLUSION: The learning curve is extremely long, so centralization and/or networking of centres is necessary to assure quality of services. One centre for every 10-15 million inhabitants would be ideal.